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ABSTRACT
The space radiation environment is a complex combination of
fast-moving ions derived from all atomic species found in the
periodic table. The energy spectrum of each ion species varies
widely but is prominently in the range of 400–600MeV/n. The
large dynamic range in ion energy is difficult to simulate in
ground-based radiobiology experiments. Most ground-based
irradiations with mono-energetic beams of a single one ion
species are delivered at comparatively high dose rates. In
some cases, sequences of such beams are delivered with vari-
ous ion species and energies to crudely approximate the com-
plex space radiation environment. This approximation may
cause profound experimental bias in processes such as bio-
logic repair of radiation damage, which are known to have
strong temporal dependencies. It is possible that this experi-
mental bias leads to an over-prediction of risks of radiation
effects that have not been observed in the astronaut cohort.
None of the primary health risks presumably attributed to
space radiation exposure, such as radiation carcinogenesis,
cardiovascular disease, cognitive deficits, etc., have been
observed in astronaut or cosmonaut crews. This fundamentally
and profoundly limits our understanding of the effects of GCR
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Why do we need yet another review of space radiation research?
Space travelers are exposed to a myriad of environmental stressors, includ-
ing chemicals from equipment,“microbes” from occupants of the space
vehicle, and microgravity, to name a few. Cosmic radiation exposures are a
particularly challenging environmental stressor because they vary strongly
in magnitude and quality with vehicle trajectory, mission duration, and
solar activity. Rare but potentially-lethal solar eruptions of protons and
other particles, which could result in mission failures, have so far proven
utterly unpredictable, precluding mission timing as a mitigation strategy.1,2
To complicate matters further, the risks to humans vary strongly with the
radiation exposure and the host, e.g., age, sex, and genetic profile of each
individual. Risk projections for individual astronauts are highly uncertain
and controversial. Although some progress has been made toward under-
standing and mitigating the risks of radiation to astronauts, the overall situ-
ation has scarcely improved since the dawn of crewed spaceflight.2,3
Several approaches are possible to mitigate space radiation risks. The use of
shielding can reduce the radiation exposures. Passive shields use bulk material
fields, e.g., the vehicle, habitat and or local regolith, to attenuate radiation,
whereas proposed magnet shields deflect charged-particle radiation away from
habituated areas.4–9 The expected exposures can be reduced by shortening the
mission, e.g., with higher-impulse propulsion systems such as ion propulsion
drives. Other approaches include radiation sensitivity as crew selection criter-
ion, biologic countermeasures (e.g., radioprotective drugs), increased medical
surveillance of exposed crew, and even pre-exposure prophylactic surgical
removal of the sensitive female breast has been proposed. More than a half
century later, intensive research has not revealed a method to fully mitigate
the radiation risk, and our understanding of the physics and biology of these
risks remains incomplete. Consequently, radiation risk prediction and manage-
ment leads as the major unmet challenge for planning future crewed missions,
especially as spaceflight missions increase and we travel outside the earth’s
protective magnetic field.2
A promising approach to solving major gaps in our knowledge on radi-
ation effects is to rely on ground based research involving animals.
Research efforts have been frustrated by a scarcity of robust biologic and
physical surrogates for such experiments. These obstacles have made it dif-
ficult to translate radiation risk models from animal models to humans.10,11
Therefore, the health risks to spaceflight explorers because of the space
radiation environment remain incompletely understood, compounded by
the disparities between findings from space-based observations of human
astronauts vs. ground-based experiments. Recently, we proposed new meth-
ods and avenues of inquiry that overcome many of the obstacles previously
encountered.12 Here we will discuss several methodological aspects of
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ground-based experimentation which, if improved, will more faithfully
mimic the complex radiation environment encountered in a variety of
spaceflight missions.
What exactly is the operational space radiation environment?
The operational space radiation environment, shown in Figure 1, can be
divided into three separate ionizing radiation sources: solar wind consisting
of mostly low energy protons and electrons, heavy-charged particles found
in the Galactic Cosmic Ray (GCR) spectrum, and energetic protons associ-
ated with a Solar Particle Event (SPE).2 The background dose rate for
solar-wind protons varies with the solar cycle (9-14 year period, average of
11 years). Even at solar maximum,the contribution is much less than that
from GCR and therefore is considered a negligible risk.3 GCR nuclei ori-
ginate from outside our solar system and possess sufficient energies to
penetrate any shielding used on current mission vehicles. As demonstrated
in Figure 2, the GCR spectrum consists of about 87% hydrogen ions (Z¼ 1
Figure 1. Components of the space radiation environment. Operational space radiation environ-
ment is comprised of three sources of ionizing radiation, energetic protons from solar particle
events, relativistic heavy ions of the galactic cosmic ray spectrum, and trapped electrons and
protons in the Van Allen Belts.
Image courtesy of ESA.
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or protons) and 12% helium ions (Z¼ 2 or alpha particles), with the
remaining 1-2% heavier nuclei with charges ranging from Z¼ 3 (Lithium)
to about Z¼ 28 (Nickel).2,13 Ions heavier than nickel are also present, but
they are rare in occurrence. The fluence (the number of incident particles
crossing a plane of unit area) of GCR particles in interplanetary space
range fluctuates inversely with the solar cycle, with dose rates of 50 to 100
mGy/year at solar maximum to 150 to 300 mGy/year at solar min-
imum.14–16 During spaceflight transit outside of low-Earth Orbit (LEO),
every cell nucleus within an astronaut would be traversed by a hydrogen
ion or energetic electron (e.g., delta ray) every few days, and by the heavier
GCR ion (e.g., oxygen, silicon, and iron ions) every few months.3 Despite
their comparatively lower fluences, heavy ions contribute a significant
amount to the GCR dose that astronauts will incur outside of LEO. Shown
in Figure 2 is the GCR flux, dose and dose equivalent up to nickel
(Z¼ 28). Light ion species such as hydrogen and helium make up most of
the GCR spectrum, but heavier ions such as silicon (Z¼ 14) and iron
(Z¼ 26) contribute significantly once the biological equivalent dose is fac-
tored in. Dose equivalent (in sieverts, Sv) is a measure of the biological
damage to living tissue as a result of radiation exposure and is calculated
Figure 2. Relative abundance of the GCR spectrum, and the contribution to dose and dose
equivalent from hydrogen (Z¼ 1) to nickel (Z¼ 28). Heavier ions such as Z¼ 26 make up a
relatively small portion of the spectrum, however, they contribute larger energy doses to the
cumulative radiation exposure than even hydrogen or helium ions.
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as the product of absorbed dose in tissue multiplied by a quality factor that
is dependent on the linear energy transfer of the radiation particulate.
The swiftest of the GCR heavy ions are so penetrating that shielding can
only partially reduce the intra-vehicular (IVA) doses.17 In theory, more
massive shielding could provide some additional protection, but in practice
this is limited by the payload lift capabilities of spacecraft launch systems.
In fact, studies have shown that aluminum shielding equivalent to 16 times
the thickness of the Apollo command module can reduce the GCR expos-
ure by up to 25%. Similarly, the equivalent mass of polyethylene, a better
shielding material but an inferior structural material, would only provide a
35% reduction in GCR dose.18,19
SPEs consist of high-energy protons that emanate from the sun in
regions of magnetic instability.20 SPE radiation is primarily composed of
protons with kinetic energies ranging from 10MeV up to several GeV. The
fluence from and occurrence of SPEs are unpredictable, but dose-rates as
high as 1500 mGy/hour (approximately 3000 mSv/hour) have been meas-
ured.21 It should be noted that the nominal dose-rate onboard the
International Space Station (ISS) is approximately 0.04 mSv/hour and pre-
dicted to be around 0.13 mSv/hour during space travel outside LEO.
During an SPE, a localized magnetic disturbance of the sun results in the
release of intense bursts of ionizing radiation that follow magnetic field
lines. Their irregular and unpredictable occurrence is evidenced by the
unusual occurrence of four comparably large SPEs in a period of 4months
during the 22nd solar cycle.7,22,23 Computer simulations reveal that the
dose distribution in an astronaut would be highly non-homogeneous, with
a relatively high superficial dose and a lower internal dose. Extravehicular
exposures carry higher risks than intravehicular exposures because the
shielding provided by the space suit is much less than that of the vehicle.
Even inside the vehicle, an SPE would still expose astronauts within the
spacecraft to non-negligible levels of radiation. Although large SPE doses
can instigate so-called late-occurring effects such as radiogenic cancer, ocu-
lar cataracts, respiratory and digestive diseases, and damage to the micro-
vasculature, these are mostly latent for many months, years, or even
decades after exposure, and by definition they should not manifest as an
immediate risk to crew health during the mission.3
As future missions are planned outside LEO and away from the protec-
tion of the Earth’s magnetic shielding, the range of possible radiation expo-
sures that astronauts may encounter is markedly different from those of
LEO. The risks from GCR and SPE exposures are increased. As previously
mentioned, massive shielding in spacecrafts can reduce but not eliminate
these exposures. In fact, collisions between GCR particles and the nuclei of
shielding materials can initiate an avalanche (sometimes called a nuclear
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cascade or shower) of nuclear reactions. Consequently, naively increasing
the shielding mass can actually increase the radiation risk from secondary
particles from the avalanches. The optimal mass of shielding to attenuate
SPE radiation is thought to be 30 to 40 g/cm2.2,12 This amount of radiation
shielding is somewhat impractical given lift capabilities in current rockets.
What analogs are used to evaluate the space radiation risk to
human health?
Animal models are used as human surrogates in studies of radiobiology to
obtain data that cannot be gained in ethical studies of humans. Many ani-
mal models have been developed to explore a wide variety of questions in
space radiation protection and medicine, e.g., radiation oncology.
Mammalian species and other advanced organisms, especially those that
can reproduce quickly and possess genomes similar to humans, have the
utility to identify mechanisms for radiation-induced effects and dis-
eases.10,24 These experiments have contributed significantly to our under-
standing of disease mechanisms, but their relevance to and suitability for
predicting outcomes in humans is controversial, e.g., for non-astronaut
patients and astronauts alike.2,25–27 A major limitation of current animal
models is that animals are, in some relevant ways, different from humans
in their response to radiation, e.g., at the cellular, organ, and organism lev-
els. Rodent models may be less well suited to test outcomes in normal tis-
sue responses to radiation in humans due to their high level of genetic
instability. There is evidence that larger mammalian models such as canines
provide a better model for radiation research. DNA repair mechanisms are
highly conserved between mammalian species, and that there is high hom-
ology between key DNA damage response genes in humans and dogs.10,28
Numerous studies in dogs have modeled normal tissue radiation response
and those studies have helped optimize human oncology care, however, no
large studies of canine models have been used in space radiation studies of
normal tissue effects.
Limitations in the ability to translate study outcomes into equivalent
health consequences in humans also result from critical disparities, usually
disease-specific, between the animal models and the human subject in clin-
ical trials and space missions, for example the development of harderian
gland tumors which only appear in mice.10,11,29 Additionally, because non-
human mammals are genetically different from humans, they may yield
results that are difficult to interpret. A growing list of genes is known to
affect radiation sensitivity phenotypes for numerous radiation effects, such
as molecular, chromosomal, signal transduction associated growth-regulat-
ing changes, cell killing, tumor acute and late effects, and animal
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carcinogens. To date, however, there is still no knowledge that would allow
a direct connection to be drawn between observed changes in gene
sequence and a corresponding change in radiosensitivity. Recently, how-
ever, Edmondson et al, demonstrated in a mouse model that the underlying
genetics of susceptibility can be similar for tumorigenesis following expos-
ure to both high- and low-LET radiation.30 This indicates that epidemi-
ology studies from human exposures to gamma radiation may be of utility
for predicting the cancer risks attributed to GCR, but further work is
needed to validate these findings.
Exactly how do you estimate radiogenic risk?
It is believed that the high linear energy transfer (LET) radiation in the
GCR spectrum can induce cancer, cognitive deficits, changes associated
with premature aging and degenerative effects in many organs. The LET
quantifies how much energy is lost by an ion, on average, per unit path-
length traversed in matter (keV/mm), and depends strongly on ion velocity
for quantification of radiobiological damage. Additionally, the large ioniza-
tion density of GCR ions makes them a potentially significant contributor
to cellular and organ damage,3,31 and therefore, it is essential to study the
potential health risks from GCR exposures. There are limitations of current
terrestrial analogs used to study and predict the effects of space radiation
on biologic systems. The mechanisms that cause biological damage from
GCR differ from those from traditional terrestrial radiation sources.
Terrestrial analogs often use radiation that causes indirect ioniz-
ing events.2,32
The biological effect of the radiation dose depends on physical and bio-
logical factors, e.g., multiple particle and energy-specific factors, dose rate
per exposure and the frequency of multiple exposures. The (physical)
absorbed dose is the energy absorbed per mass (J/Kg, Gy). For a dose-based
system of radiation protection and for the determination of occupational
dose limits, it is necessary to attempt summing the total risk of radiation
from multiple sources (e.g., SPE protons, GCR, etc.).33 At a given ion vel-
ocity, LET increases with atomic number. Thus, for ground-based research,
it is key to have the correct abundances and energy distributions of each
ion present in the space radiation environment. As charged particles lose
energy successively through material interactions, each energy loss event
can result in damage to the biological tissue. In addition, as charged par-
ticles near the end of their track (i.e., as they slow down and are nearly
stopped) the LET rises sharply, creating the so-called “Bragg peak”.34 This
is demonstrated in Figure 3. The phenomenon of the Bragg peak is
exploited in cancer therapy in order to concentrate the dose at the target
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH. PART C. TOXICOLOGY AND CARCINOGENESIS 119
tumor while minimizing impact to the surrounding tissue. This is demon-
strated in Figure 3 where the relative dose deposition in tissue for various
radiation types utilized in space radiobiology studies is plotted versus depth
in tissue. The gray shaded area is the average width of a mouse model.
Also shown are the average diameters of Yucatan mini-pigs and humans.
Gamma and X-ray radiations deposit most of the energy at or near the sur-
face, while in contrast, charged particles such as protons, carbon, iron, etc.,
have distinct Bragg peaks. In each example, the Bragg peak is located out-
side the body mass of the mouse, indicating the difficulty in replicating the
relative organ dose distribution of a GCR exposure incurred by humans
during spaceflight.
The relative biological effectiveness (RBE) quantifies how much energy is
required for a test radiation (e.g., 1-GeV protons) compared to a reference
radiation (e.g., 140KeV x-rays). RBE depends on ion charge and speed, the
cell, organ, or tissue of interest, and the endpoint considered, (e.g., lethal
damage and carcinogenesis). To facilitate the aggregation of risk to a
human, variations in radiation sensitivities in various tissues and organs
are incorporated in a tissue weighting factor. Similarly, variations in radi-
ation sensitivity with ion properties are taken into account with radiation
weighting factors, which are informed by RBE values (mostly for the end-
point of carcinogenesis). Additional factors may be applied to take into
Figure 3. Bragg peak and depth dose characteristics of space radiation. Shown in the figure
are the calculated Bragg peaks and relative dose deposition for ions at energies commonly
used in space radiation studies. These are compared to the x-ray and gamma sources used as
surrogate radiations for RBE quantification. This effect is very pronounced for fast moving,
charged particles. Shown are 60MeV protons (hydrogen, purple), 600MeV/n 56Fe (iron, light
blue), 290MeV/n 12C (carbon, green), 1 GeV/n 56Fe (iron, dark blue), x-ray (orange dotted line),
and 60Co (cobalt, yellow dotted line). The shaded gray area, representing the average diameter
of a mouse, demonstrates that the Bragg peak, and thus the majority of dose deposition, is
outside the mouse body for SPE protons (energies 50MeV/n) and GCR ions. Figure reprinted
with permission from Chancellor et al.2 under the Creative Commons license.
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account variations in dose, dose rate, and other factors. Combining the
physical absorbed dose and the various biologic considerations mentioned,
one obtains an “equivalent dose” in units of Sieverts (Sv) that ideally is
proportional to risk in the subject or population being considered.33,34
In the US, radiation therapy with charged particles is dominated by pro-
tons. An RBE value for proton beams was recommended at 1.1 for all end-
points, tissues, doses, LET values, and dose rates. This consensus
recommendation was made mainly to increase consistency in dose prescrip-
tion and reporting among proton therapy centers. It also is believed to
facilitate pooling of data from observational data from photon beam treat-
ments. Importantly, to date, there remains insufficient evidence that the
RBE is significantly different from 1.0 for any human tissue for any end-
point. The ICRU [report 78] and the 2019 report from the American
Association of Physicists in Medicine described limitations in RBE data for
clinical purposes. Based on the lack of evidence outlined above, we can
conclude that many of the same gaps in knowledge comprise obstacles to
reliable risk predictions in both radiation oncology and crewed space-
flight.35,36 This suggests the possibility of synergistic research studies of
open questions in oncology and space exploration.
What outcomes have been seen in astronauts so far?
Since the onset of crewed spaceflight, it has been presumed that exposure
to space radiation increases the risks of astronauts developing cancer, expe-
riencing central nervous system decrements, exhibiting degenerative tissue
effects or developing acute radiation syndrome.1–3,20,25,37,38 The majority of
epidemiologic data resulting from the astronaut cohort are from exposures
incurred on missions during the Space Shuttle era, where less than 100
mSv was accumulated by an astronaut. Over the past decade, however, the
nominal mission length for astronauts has increased to at least 6months in
duration with exposures of 1 mSv to 1.5 mSv per day, depending on the
phase of the solar cycle, number of spacewalks performed, and level of
solar activity. Even with increasing mission length and radiation exposures
(e.g., Figure 4), it is noteworthy that to date no astronaut has been diag-
nosed with a cancer that is attributable to space radiation. Although the
sample size is small, followup times for large exposures are limited, and
cancer latency periods are years to decades. In addition, the neurocognitive
deficits and vascular endothelial dysfunction leading to increased cardiovas-
cular mortality have not been demonstrated compared to analog
populations.
The presumed risk of cancer, cardiovascular diseases and cognitive defi-
cits due to space radiation remains one of NASA’s top limiting factors as
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we return to the moon and push forward toward Mars. The limitations in
knowledge of radiogenic risks have been one of the key factors that can
limit an astronaut’s potential flight assignments as well as active space-
flight-career length.
Figure 4 demonstrates the amount of data obtained by both NASA and
the Russian Space Agency in regards to number of astronauts and dose of
radiation obtained over varying lengths of spaceflight. Recently Zeitlin
et al., reported findings that the LET spectrum measured inside ISS at high
latitudes was similar to measurements made both in lunar orbit and in
interplanetary space during transit to Mars.39 This demonstrates that we
now have an increasing data set of humans that have flown in space while
exposed to doses that in some instances exceed the identified thresholds for
some degenerative and carcinogenic outcomes. Given the decades of
ground-based radiobiologic research on radiation effects in space travel,
one can only conclude that animal models and the type of radiation uti-
lized in these experiments are not adequate surrogates for the complex
physiologic response of the human body to the complex radiation environ-
ment in space.
Wait, so astronauts can sign off on being launched into space, but not
on an unproven health risk?
For decades there have been concerns about the clinical sequelae of United
States astronauts’ exposure to the complex radiation environment of space-
flight. The National Council of Radiation Protection and Measurements
(NCRP) recommended to NASA that a career limit be placed on astronaut
Figure 4. Cumulative mission dose for all astronauts and cosmonauts through 2020. Shown are
the number of astronauts (NASA, ESA, CSA, JAXA) and cosmonauts whose cumulative mission
exposures have exceeded dose thresholds up to 500 mSv. It should be noted that these were
long-duration flyers, e.g., where missions of 3months or longer are typical.
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radiation exposure which when adjusted for age and sex, would not
increase an astronaut’s risk of death by greater than 3%. This risk of expos-
ure-induced death (REID) was first suggested by NRCP Report 98 and is
based on a two-sided 95% confidence interval for estimates of mortality
from malignancy.21 Little justification was given as to why a 3% REID was
chosen, relative to a higher or lower threshold. At that time, it was sug-
gested that a 25 year old male astronaut would be able to accomplish 17
Space Shuttle missions of 90 days duration over a 10 year period prior
before violating this REID. This proposed limit represented a reasonable
ceiling given the available information as no astronaut in the 1980s flew at
this frequency or duration. However, the United States space program has
fundamentally changed and astronauts now regularly complete 6 to
12month missions aboard the ISS. Long-duration missions to Mars and
the Moon are expected during the next two decades and could last
1-3 years.
In clinical practice, medical providers and bioethicists often refer to four
principles which guide medical decision making: autonomy, non-malefi-
cence, beneficence, and justice. The first of these principles, autonomy,
requires patients to have independent thought, intention and action when
making decisions regarding their own health.40 In order to abide by the
principle of autonomy, patients must fully understand the risks and bene-
fits of any medical decision, including options which increase personal risk
or include non-treatment. Patients must be empowered to have informed
consent about the treatment options, or lack thereof, for any medical con-
dition. Fortunately, in common medical scenarios such as chest pain, pedi-
atric fever, or the risk of pulmonary embolism, there are clinical decision
rules based on robust, prospective, and externally validated clinical trials
that stratify the patient’s individual risk.
Exploration of space is not without risks. Space agencies have rigorous
safety programs and oversight to limit risk during missions planning,
spacecraft design, and throughout the stages of flight. With regards to space
radiation, it is important to acknowledge current limitations in the under-
standing of the impacts on human morbidity and mortality. The estima-
tions of risk from space radiation are likely not as precise as the risk of
vehicle loss during launch or reentry. As noted in this manuscript, there
are no validated clinical decision rules that medical providers and flight
surgeons can use to precisely assess the clinical risk from space radiation.
However, the principle of autonomy requires that medical providers pro-
vide patients, in this case astronauts, with the best information available
and its limitations so they can make informed decisions regarding the risks
from space radiation. Using such information, an astronaut may wish to
exceed their strict personal 3% REID for the opportunity to fly specific
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missions or achievements, such as returning to the Moon or being the first
to travel to Mars.
Exploration of space, however, is not an individual endeavor. The launch
and safe return of astronauts is supported by thousands of engineers, scien-
tists, administrators, and the American public. Missions further science on
behalf of citizens and taxpayers, not individual astronauts. Although we
believe astronauts should be empowered to make decisions about their per-
sonal risk tolerance from radiation, such practices when left unregulated,
may lead to group-think and development of unsafe practices. Astronauts
and leaders at government and commercial spaceflight companies face a
challenge of balancing individual autonomy, medical risk, and the proper
stewardship of agency resources.
Given the nature of exploration spaceflight, extremely strict limits of
radiation exposure may not be practical. Missions to the Moon or Mars
may violate an astronaut’s 3% REID simply due to mission duration. We
believe that further research is needed to provide insight into an astronaut’s
individual risk of morbidity and mortality from space radiation. This infor-
mation is critical so that mutual, pragmatic, and ethically sound decision-
making can take place between astronauts, medical providers, and space
agency administrators
So what does all of this mean?
A limitation in space radiation effects research has been a lack of suitable
accelerator-produced radiation sources that accurately reproduce GCR at
terrestrial laboratories. Bench studies have used mono-energetic beams and
acute, single-ion exposures or multiple ions in sequence, instead of the
poly-energetic spectra of multiple ion species present in the space radiation
environment.41–43 Furthermore, for ease of dose specification and model-
ing, ions in the 100MeV/n to 1000MeV/n range were often used, such that
the entire target was contained within the plateau portion of the depth-
dose distribution as demonstrated in Figure 3.2,44,45 Additionally, a pro-
jected, cumulative mission dose is often delivered to the animals over a sin-
gle acute exposure; as such, the experimental dose rates are several orders
of magnitude higher than actual space exposures.2,45 Even the more
recently used prolonged fractionated exposures may not fully mimic the
continuous low dose rates found in space.
The ability to better simulate the space radiation environment through
terrestrial research efforts would greatly facilitate advances in our under-
standing of the risks to human health during long-duration spaceflight.
There has been progress toward realistic ground-based space radiation ana-
logs. NASA’s GCR simulator provides some improvements to simulation
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studies by use of rapid-sequential mono-electric beam exposures.46 There is
debate in the space radiation community with respect to the appropriate
order of ion exposures delivered, where the alteration of exposure sequence
can affect the outcomes of an experiment.2,25,47 Sequential beam exposures
remain ineffective in modeling complex and simultaneous exposures of the
actual GCR environment.48,49 Additionally, Chancellor et al., have demon-
strated that a moderator block can be placed in a single-ion-species beam
without any requirement to modify the beamline and related infrastruc-
ture.12 As an iron beam passes through the moderator block, nuclear spal-
lation processes create desired fragment spectra, resulting in fluences of
charged particles with atomic numbers of 1  Z 26 and LETs up to
approximately 200 keV/mm. That is to say, the ion species and their distri-
butions in energy closely mimic those of GCR.
Taken together, the limitations of terrestrial GCR-like sources and animal
models have been major obstacles to understanding responses at chronic,
low-dose and low-dose rate radiation conditions. Even partially eliminating
one of these limitations may help researchers to explain the frequent dis-
parity between data from ground-based studies and those from astronauts.
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